This work is licensed under the Creative Commons Attribution-NonCommercial-NoDerivatives 3.0 License.
Smyth AR, Bell SC, Bojcin S, BryonM, Duff A, Flume P, et al. European Cystic Fibrosis Society standards of care: Best practice guidelines. J Cyst Fibros. 2014; 13(Suppl 1): S23-S42.SmythARBellSCBojcinSBryonMDuff AFlumePet alEuropean Cystic Fibrosis Society standards of care: Best practice guidelines201413Suppl 1S23S4210.1016/j.jcf.2014.03.010Search in Google Scholar
Castellani C, Duff AJA, Bell SC, Heijerman HGM, Munck A, Ratjen F, et al. ECFS best practice guidelines: The 2018 revision. J. Cyst Fibros. 2018; 17(2): 153-178.CastellaniCDuffAJABellSCHeijermanHGMMunckARatjenFet alECFS best practice guidelines: The 2018 revision201817215317810.1016/j.jcf.2018.02.006Search in Google Scholar
Castellani C, Southern KW, Brownlee K, Roelse JD, Duff A, Farrell M, et al. European best practice guidelines for cystic fibrosis neonatal screening. J Cyst Fibros. 2009; 8(3): 153-173.CastellaniCSouthernKWBrownleeKRoelseJDDuffAFarrellMet alEuropean best practice guidelines for cystic fibrosis neonatal screening20098315317310.1016/j.jcf.2009.01.004Search in Google Scholar
Travert G, Heeley M, Heeley A. History of newborn screening for cystic fibrosis–The early years. Int J Neonatal Screen. 2020; 6(1): 8.TravertGHeeleyMHeeleyAHistory of newborn screening for cystic fibrosis–The early years202061810.3390/ijns6010008Search in Google Scholar
Scotet V, Gutierrez H, Farrell PM. Newborn screening for CF across the globe– Where is it worthwhile? Int J Neonatal Screen. 2020; 6(1): 18.ScotetVGutierrezHFarrellPMNewborn screening for CF across the globe–2020611810.3390/ijns6010018Search in Google Scholar
Farrell PM, Rosenstein BJ, White TB, Accurso FJ, Castellani C, Cutting GR, et al.; Cystic Fibrosis Foundation. Guidelines for diagnosis of cystic fibrosis in newborns through older adults: Cystic fibrosis foundation consensus report. J Pediatr. 2008; 153(2): S4-S14.FarrellPMRosensteinBJWhiteTBAccursoFJCastellaniCCuttingGRet alCystic Fibrosis Foundation. Guidelines for diagnosis of cystic fibrosis in newborns through older adults: Cystic fibrosis foundation consensus report20081532S4S1410.1016/j.jpeds.2008.05.005Search in Google Scholar
Farrell PM, White TB, Howenstine MS, Munck A, Parad RB, Rosenfeld M, et al. Diagnosis of cystic fibrosis in screened populations. J Pediatr. 2017; 181(Suppl): S33-S44.e2.FarrellPMWhiteTBHowenstineMSMunckAParadRBRosenfeldMet alDiagnosis of cystic fibrosis in screened populations2017181SupplS33S44.e210.1016/j.jpeds.2016.09.065Search in Google Scholar
Noveski P, Madjunkova S, Mircevska M, Plaseski T, Filipovski V, Plaseska-Karanfilska D. SNaPshopt assay for the detection of the most common mutations in infertile men. PLoS One. 2014; 9(11): e112498.NoveskiPMadjunkovaSMircevskaMPlaseskiTFilipovskiVPlaseska-KaranfilskaDSNaPshopt assay for the detection of the most common mutations in infertile men2014911e11249810.1371/journal.pone.0112498Search in Google Scholar
Terzic M, Jakimovska M, Fustik S, Jakovska T, Sukarova-Stefanovska E, Plaseska-Karanfilska D. Cystic fibrosis mutation spectrum in North Macedonia: A step toward personalized therapy. Balkan J Med Genet. 2019; 22(1): 35-40.TerzicMJakimovskaMFustikSJakovskaTSukarova-StefanovskaEPlaseska-KaranfilskaDCystic fibrosis mutation spectrum in North Macedonia: A step toward personalized therapy2019221354010.2478/bjmg-2019-0009Search in Google Scholar
Naehrlich L. The changing face of cystic fibrosis and its implications for screening. Int J Neonatal Screen. 2020; 6(3): 54.NaehrlichLThe changing face of cystic fibrosis and its implications for screening2020635410.3390/ijns6030054Search in Google Scholar
Farrell PM, Kosorok MR, Rock MJ, Laxova A, Zeng L, Lai HC, et al. Early diagnosis of cystic fibrosis through neonatal screening prevents severe malnutrition and improves long-term growth. Wisconsin Cystic Fibrosis Neonatal Screening Study Group. Pediatrics. 2001; 107(1): 1-13.FarrellPMKosorokMRRockMJLaxovaAZengLLaiHCet alEarly diagnosis of cystic fibrosis through neonatal screening prevents severe malnutrition and improves long-term growth2001107111310.1542/peds.107.1.1Search in Google Scholar
Mak DYF, Sykes J, Stephenson AL, Lands LC. The benefits of newborn screening for cystic fibrosis: The Canadian experience. J Cyst Fibros. 2016; 15(3): 302-308.MakDYFSykesJStephensonALLandsLCThe benefits of newborn screening for cystic fibrosis: The Canadian experience201615330230810.1016/j.jcf.2016.04.001Search in Google Scholar
Siret D, Bretaudeau G, Branger B, Dabadie A, Dagorne M, David V, et al. Comparing the clinical evolution of cystic fibrosis screened neonatally to that of cystic fibrosis diagnosed from clinical symptoms: A 10-year retrospective study in a French region (Brittany). Pediatr Pulmonol. 2003; 35(5): 342-349.SiretDBretaudeauGBrangerBDabadieADagorneMDavidVet alComparing the clinical evolution of cystic fibrosis screened neonatally to that of cystic fibrosis diagnosed from clinical symptoms: A 10-year retrospective study in a French region (Brittany)200335534234910.1002/ppul.10259Search in Google Scholar
Schluter DK, Southern KW, Dryden C, Diggle P, Taylor-Robinson D. Impact of newborn screening on outcomes and social inequalities in cystic fibrosis: A UK CF registry-based study. Thorax. 2020; 75(2): 123-131.SchluterDKSouthernKWDrydenCDigglePTaylor-RobinsonDImpact of newborn screening on outcomes and social inequalities in cystic fibrosis: A UK CF registry-based study202075212313110.1136/thoraxjnl-2019-213179Search in Google Scholar
Davies G, Stocks J, Thia LP, Hoo A-F, Bush A, Aurora P, et al. Pulmonary function deficits in newborn screened infants with cystic fibrosis managed with standard UK care are mild and transient. Eur Respir J. 2017; 50(5): 1700326.DaviesGStocksJThiaLPHooA-FBushAAuroraPet alPulmonary function deficits in newborn screened infants with cystic fibrosis managed with standard UK care are mild and transient2017505170032610.1183/13993003.00326-2017Search in Google Scholar
Tridello G, Castellani C, Meneghelli I, Tamanini A, Assael BM. Early diagnosis from newborn screening maximises survival in severe cystic fibrosis. ERJ Open Res. 2018; 4(2): 00109-2017.TridelloGCastellaniCMeneghelliITamaniniAAssaelBMEarly diagnosis from newborn screening maximises survival in severe cystic fibrosis20184200109201710.1183/23120541.00109-2017Search in Google Scholar
Nshimyumukiza L, Bois A, Daigneault P, Lands L, Laberge AM, Fournier D, et al. Cost effectiveness of newborn screening for cystic fibrosis: A simulation study. J Cyst Fibros. 2014; 13(3): 267-274.NshimyumukizaLBoisADaigneaultPLandsLLabergeAMFournierDet alCost effectiveness of newborn screening for cystic fibrosis: A simulation study201413326727410.1016/j.jcf.2013.10.012Search in Google Scholar
Castellani C, Massie J, Sontag M, Southern KW. Newborn screening for cystic fibrosis. Lancet Respir Med. 2016; 4(8): 653-661.CastellaniCMassieJSontagMSouthernKWNewborn screening for cystic fibrosis20164865366110.1016/S2213-2600(16)00053-9Search in Google Scholar
Barben J, Castellani C, Dankert-Roelse J, Gartner S, Kashirskaya N, Linnane B, et al. The expansion and performance of national newborn screening programmes for cystic fibrosis in Europe. J Cyst Fibros. 2017; 16(2): 207-213.BarbenJCastellaniCDankert-RoelseJGartnerSKashirskayaNLinnaneBet alThe expansion and performance of national newborn screening programmes for cystic fibrosis in Europe201716220721310.1016/j.jcf.2016.12.012Search in Google Scholar
Munck A, Mayell SJ, Winters V, Shawcross A, Derichs N, Parad R, et al. Cystic fibrosis screen positive, inconclusive diagnosis (CFSPID): A new designation and management recommendations for infants with an inconclusive diagnosis following newborn screening. J Cyst Fibros. 2015; 14(6): 706-713.MunckAMayellSJWintersVShawcrossADerichsNParadRet alCystic fibrosis screen positive, inconclusive diagnosis (CFSPID): A new designation and management recommendations for infants with an inconclusive diagnosis following newborn screening201514670671310.1016/j.jcf.2015.01.001Search in Google Scholar
Southern KW, Barben J, Gartner S, Munck A, Castellani C, Mayell SJ, et al. Inconclusive diagnosis after a positive newborn bloodspot screening result-for cystic fibrosis; clarification of the harmonised international definition. J Cyst Fibros. 2019; 18(6): 778-780.SouthernKWBarbenJGartnerSMunckACastellaniCMayellSJet alInconclusive diagnosis after a positive newborn bloodspot screening result-for cystic fibrosis; clarification of the harmonised international definition201918677878010.1016/j.jcf.2019.04.010Search in Google Scholar
Munck A. Inconclusive diagnosis after newborn screening for cystic fibrosis. Int J Neonatal Screen. 2020; 6(1): 19.MunckAInconclusive diagnosis after newborn screening for cystic fibrosis2020611910.3390/ijns6010019Search in Google Scholar
Rusakow LS, Frank J, Accurso FJ. Immunoreactive trypsinogen levels in infants with cystic fibrosis complicated by meconium ileus. Screening. 1993; 2: 13-17.RusakowLSFrankJAccursoFJImmunoreactive trypsinogen levels in infants with cystic fibrosis complicated by meconium ileus19932131710.1016/0925-6164(93)90013-9Search in Google Scholar
Repeto T, Mergni G, Revenni N, Zavataro L, Braggion C. Delay in meconium emission: Should it be considered a risk for cystic fibrosis. [Abstract 46]. J Cyst Fibros. 2011; 11(Suppl 1): S12-S46.RepetoTMergniGRevenniNZavataroLBraggionCDelay in meconium emission: Should it be considered a risk for cystic fibrosis201111Suppl 1S12S4610.1016/S1569-1993(11)60066-0Search in Google Scholar